অনুসন্ধান ফলাফলগুলি - Claire Mahoney
- প্রদর্শন 1 - 3 ফলাফল এর 3
-
1
LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition অনুযায়ী Claire Mahoney, Bhudipa Choudhury, Helen Davies, Sarah Edkins, Chris Greenman, Gijs van Haaften, Tatiana Mironenko, Thomas Santarius, Claire Stevens, Michael R. Stratton, P. Andrew Futreal
প্রকাশিত 2009Artigo -
2
-
3
Synthetic Lethal Targeting of <i>ARID1A</i>-Mutant Ovarian Clear Cell Tumors with Dasatinib অনুযায়ী Rowan Miller, Rachel Brough, Ilirjana Bajrami, Chris T. Williamson, Simon S. McDade, James Campbell, Asha Kigozi, Rumana Rafiq, Helen N. Pemberton, Rachael Natrajan, Josephine Joel, Holly Astley, Claire Mahoney, Jonathan D. Moore, Chris Torrance, John D. Gordan, James T. Webber, Rebecca S. Levin, Kevan M. Shokat, Sourav Bandyopadhyay, Christopher J. Lord, Alan Ashworth
প্রকাশিত 2016Artigo
অনুসন্ধান সাধনীগুলি:
সম্পর্কিত বিষয়
Biology
Cancer
Cancer research
Gene
Genetics
Medicine
Mutant
Mutation
ARID1A
Amplicon
Biochemistry
Carcinogenesis
Cell growth
Chemotherapy
Cisplatin
Clear cell carcinoma
Dasatinib
Enzyme
Gene duplication
Gene knockdown
Germline
Germline mutation
Imatinib
In vivo
Internal medicine
KRAS
Kinase
Lung cancer
MAPK/ERK pathway
Molecular biology